AI Journal

AI Journal

AI Journal's Articles

BioTec Sets New Market Standards with Fusion-Based Bio Solutions, Aiming for Global Expansion

BioTec Sets New Market Standards with Fusion-Based Bio Solutions, Aiming for Global Expansion

SEOUL, South Korea, Dec. 16, 2025 /PRNewswire/ — BioTec’s new releases are attracting attention as technology-fusion solutions rarely seen in the current market

Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock

Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock

PALO ALTO, Calif., Dec. 16, 2025 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching

Advantech Expands Global Edge AI Partner Ecosystem with DEEPX and Launches First Joint Solution

Advantech Expands Global Edge AI Partner Ecosystem with DEEPX and Launches First Joint Solution

TAIPEI, Dec. 16, 2025 /PRNewswire/ — Advantech, a global leader in IoT intelligent systems and embedded platforms, today announced its partnership with DEEPX, a

Mori Memorial Foundation’s Global Power City Index 2025 Sees City Rankings Shift Due to Tourism Gains in East Asia and Inflationary Pressures in the West

Mori Memorial Foundation’s Global Power City Index 2025 Sees City Rankings Shift Due to Tourism Gains in East Asia and Inflationary Pressures in the West

TOKYO–(BUSINESS WIRE)–The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape

SCENTMATIC’s AI “KAORIUM” Makes Hong Kong Debut at Grand Opening of @cosme HONG KONG

SCENTMATIC’s AI “KAORIUM” Makes Hong Kong Debut at Grand Opening of @cosme HONG KONG

HONG KONG–(BUSINESS WIRE)–SCENTMATIC Inc. (CEO: Toshiharu Kurisu, Headquarters: Tokyo, hereinafter “SCENTMATIC”), a company dedicated to proposing new customer

Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma

Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma

Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype Approval

TIER IV invests in Taiwan-based autonomous driving startup Turing Drive

TIER IV invests in Taiwan-based autonomous driving startup Turing Drive

TOKYO, Dec. 16, 2025 /PRNewswire/ — TIER IV, the pioneering force behind open-source software for autonomous driving, has invested in Turing Drive, a Taiwan-based

KIOXIA AiSAQ Technology Integrated into Milvus Vector Database

KIOXIA AiSAQ Technology Integrated into Milvus Vector Database

Integration Natively Extends Vector Index Scalability While Minimizing DRAM Footprint Within Industry Leading Open-Source Database SAN JOSE, Calif.–(BUSINESS WIRE

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases

Sushi Announces Strategic Investment and New Leadership to Accelerate Next Phase of Growth

Sushi Announces Strategic Investment and New Leadership to Accelerate Next Phase of Growth

NEW YORK, Dec. 16, 2025 /PRNewswire/ — This week, Sushi announced a major strategic development in the protocol’s long-term roadmap, backed by a significant investment